Last reviewed · How we verify
NCT05361161
Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)
Phase 2 trial testing Transarterial Chemoembolization in Gastric Cancer in 60 participants. Status unknown.
1 December 2022
Quick facts
| Lead sponsor | Gang Wu |
|---|---|
| Phase | Phase 2 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 June 2022 |
| Primary completion | 1 December 2022 |
| Estimated completion | 1 December 2025 |
Drugs / interventions tested
- Transarterial Chemoembolization — full drug profile →
Conditions studied
- Gastric Cancer — all drugs for Gastric Cancer →
- Embolization — all drugs for Embolization →
Sponsor
Gang Wu — full company profile →
Who can join
Adults 18 to 80, any sex, with Gastric Cancer or Embolization. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, open-labelled study to evaluate the efficacy and safety of sequential transarterial chemoembolization with lipiodol and neoadjuvant chemotherapy in the treatment of Initial unresectable gastric cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05361161
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transarterial Chemoembolization
Trials testing the same drug.
- NCT06261814 — Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors · Phase 2 · recruiting
- NCT06503250 — A Study of Participants With Initially Unresectable Hepatocellular Carcinoma That is Treated With Atezolizumab and Bevac · completed
- NCT05672108 — Phase II Trial of Lung Chemoemobolization · Phase 2 · recruiting
- NCT05233358 — HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure · NA · unknown
- NCT04728633 — Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases · Phase 2 · active not recruiting
Other recruiting trials for Gastric Cancer
Currently open trials in the same condition.
- NCT07525765 — AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer · recruiting
- NCT07464470 — Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers · recruiting
- NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
- NCT07431281 — Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Meta · Phase 3 · recruiting
- NCT07448493 — Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer · active not recruiting
Other Gang Wu trials
Trials by the same sponsor.
- NCT06127329 — Efficacy and Safety of BAI Combined With DEB-BACE of EqualSpheres in the Treatment of Advanced NSCLC · NA · not yet recruiting
- NCT05380271 — Efficacy and Safety of DEB-BACE With Sequential Arotinib and Tirelizumab in the Treatment of Advanced NSCLC · Phase 2 · unknown
- NCT05340231 — An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Tre · Phase 2 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05361161 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gang Wu
- Last refreshed: 24 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05361161.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing